Perspective Therapeutics, Inc. — Form D

Perspective Therapeutics, Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-22. The offering totals $20.8M, of which $20.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Michael McCormickDirectorNew York, NY
Robert Williamson IIIDirectorSeattle, WA
Frank MorichDirectorBoston, MA
Johan (Thijs) SpoorDirectorSeattle, WA
Johan (Thijs) SpoorExecutive OfficerSeattle, WA
Lori WoodsDirectorSeattle, WA
Mark AustinExecutive OfficerSeattle, WA
Heidi HensonDirectorSeattle, WA
Jonathan HuntExecutive OfficerNew York, NY
Markus PuhlmannExecutive OfficerSeattle, WA
Jennifer StreeterExecutive OfficerRichland, WA
William J CavanaghExecutive OfficerRichland, WA
Michael W McCormickDirectorScottsdale, AZ
Lori A WoodsDirectorRichland, WA
Lori A WoodsExecutive OfficerRichland, WA
Jennifer J StreeterExecutive OfficerRichland, WA
Mark J AustinExecutive OfficerRichland, WA
Michael J KrachonExecutive OfficerRichland, WA
Alan J HoffmannDirectorPhoenix, AZ
Philip J VitaleDirectorScottsdale, AZ

Other filings by this issuer (3)

FiledFormOfferingSold
2024-03-18D$87.4M$87.4M
2023-02-21D$54.6M$54.6M
2018-07-25D$729K$729K

More